BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2602904)

  • 1. Serum procollagen III peptide in alcoholic and other chronic liver diseases.
    Bell H; Raknerud N; Orjasaeter H; Haug E
    Scand J Gastroenterol; 1989 Dec; 24(10):1217-22. PubMed ID: 2602904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
    Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
    Nouchi T; Worner TM; Sato S; Lieber CS
    Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibronectin concentrations in patients with liver diseases.
    Gluud C; Dejgaard A; Clemmensen I
    Scand J Clin Lab Invest; 1983 Oct; 43(6):533-7. PubMed ID: 6658370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
    Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
    Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alcohol and liver diseases].
    Weigand K; Kühn HA
    Med Klin; 1980 Jul; 75(14):506-10. PubMed ID: 7402166
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers.
    Annoni G; Colombo M; Cantaluppi MC; Khlat B; Lampertico P; Rojkind M
    Hepatology; 1989 May; 9(5):693-7. PubMed ID: 2707736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
    Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
    Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease.
    Henriksen JH; Bentsen KD; Laurent TC
    J Hepatol; 1988 Apr; 6(2):158-66. PubMed ID: 3411097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C in patients with alcoholic cirrhosis and other liver diseases.
    Bell H; Odegaard OR; Andersson T; Raknerud N
    J Hepatol; 1992 Mar; 14(2-3):163-7. PubMed ID: 1500680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
    Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
    Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol and retinyl esters in patients with alcoholic liver disease.
    Bell H; Nilsson A; Norum KR; Pedersen LB; Raknerud N; Rasmussen M
    J Hepatol; 1989 Jan; 8(1):26-31. PubMed ID: 2921501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
    Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
    Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology.
    Trinchet JC; Hartmann DJ; Pateron D; Munz-Gotheil C; Callard P; Ville G; Beaugrand M
    Alcohol Clin Exp Res; 1992 Apr; 16(2):342-6. PubMed ID: 1590556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin in liver disease and its relationship to gynaecomastia.
    Morgan MY; Jakobovits AW; Gore MB; Wills MR; Sherlock S
    Gut; 1978 Mar; 19(3):170-4. PubMed ID: 631637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, biochemical and pathological correlation in alcoholic liver disease among Indian patients.
    Mukhopadhyay P; Saha S; Philips CA; Sinha U
    Trop Gastroenterol; 2012; 33(3):218-20. PubMed ID: 23600054
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum prealbumin, transferrin and immunoglobulins in fatty liver, alcoholic cirrhosis and primary biliary cirrhosis.
    Teppo AM; Maury CP
    Clin Chim Acta; 1983 Apr; 129(3):279-86. PubMed ID: 6851168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.